![Jean Fan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean Fan
Direttore Tecnico/Scientifico/R&S presso
NEOIMMUNETECH, INC.
Profilo
Jean Fan currently works at TransThera Sciences (Nanjing), Inc., as Chief Medical Officer from 2022 and NeoImmuneTech, Inc., as Chief Clinical Officer from 2021.
Dr. Fan also formerly worked at Blueprint Medicines Corp., as Vice President-Clinical Development.
Posizioni attive di Jean Fan
| Società | Posizione | Inizio |
|---|---|---|
| NEOIMMUNETECH, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
| TRANSTHERA SCIENCES (NANJING), INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2022 |
Precedenti posizioni note di Jean Fan
| Società | Posizione | Fine |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
34
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
NeoImmuneTech, Inc.
 NeoImmuneTech, Inc. BiotechnologyHealth Technology Develops novel immuno-therapeutics | Health Technology |
TransThera Sciences (Nanjing), Inc.
 TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focusing on discovering and developing small molecule therapies | Health Technology |
